Literature DB >> 16844879

Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension.

G Barbaro, A Lucchini, A M Pellicelli, B Grisorio, G Giancaspro, G Barbarini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16844879      PMCID： PMC1861099          DOI： 10.1136/hrt.2005.076794

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy.

Authors:  Jean-Philippe Zuber; Alexandra Calmy; John M Evison; Barbara Hasse; Veronique Schiffer; Thomas Wagels; Reto Nuesch; Lorenzo Magenta; Bruno Ledergerber; Rolf Jenni; Rudolf Speich; Milos Opravil
Journal:  Clin Infect Dis       Date:  2004-04-01       Impact factor: 9.079

2.  Bosentan therapy for pulmonary arterial hypertension.

Authors:  Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael Landzberg; Gerald Simonneau
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

3.  Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Authors:  R N Channick; G Simonneau; O Sitbon; I M Robbins; A Frost; V F Tapson; D B Badesch; S Roux; M Rainisio; F Bodin; L J Rubin
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

4.  Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

Authors:  R V Aguilar; H W Farber
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

5.  Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Virginie Gressin; Rudolf Speich; Peter S Macdonald; Milos Opravil; David A Cooper; Thierry Fourme; Marc Humbert; Jean-François Delfraissy; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2004-08-18       Impact factor: 21.405
  5 in total
  13 in total

Review 1.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

2.  Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats.

Authors:  Guillaume Gary-Bobo; Amal Houssaini; Valerie Amsellem; Dominique Rideau; Pierre Pacaud; Aline Perrin; Jérémy Brégeon; Elisabeth Marcos; Jean-Luc Dubois-Randé; Olivier Sitbon; Laurent Savale; Serge Adnot
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 3.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

4.  Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension.

Authors:  M Patricia George; Hunter C Champion; Marc Simon; Siobhan Guyach; Rebecca Tarantelli; Heather M Kling; Alexandra Brower; Christopher Janssen; Jessica Murphy; Jonathan P Carney; Alison Morris; Mark T Gladwin; Karen A Norris
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

5.  Heart and HAART: Two sides of the coin for HIV-associated cardiology issues.

Authors:  Giuseppe Barbaro
Journal:  World J Cardiol       Date:  2010-03-26

6.  Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques.

Authors:  M Patricia George; Alexandra Brower; Heather Kling; Tim Shipley; Jan Kristoff; Todd A Reinhart; Michael Murphey-Corb; Mark T Gladwin; Hunter C Champion; Alison Morris; Karen A Norris
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

Review 7.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

8.  Pulmonary arterial hypertension related to human immunodeficiency virus infection: A case series.

Authors:  Inês Araújo; Cristina Enjuanes-Grau; Carmen Jimenez Lopez-Guarch; Dariusz Narankiewicz; Maria J Ruiz-Cano; Teresa Velazquez-Martin; Juan Delgado; Pilar Escribano
Journal:  World J Cardiol       Date:  2014-06-26

Review 9.  Human immunodeficiency virus & cardiovascular risk.

Authors:  Giuseppe Barbaro; Giorgio Barbarini
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

10.  Pulmonary arterial hypertension: an update.

Authors:  E S Hoendermis
Journal:  Neth Heart J       Date:  2011-12       Impact factor: 2.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.